B · Normal
On October 7, Bernstein lowered AstraZeneca's target price from 20,200 pence per share to 19,800 pence.
Related telegraphs
[U.S. Treasury Secretary: The U.S. national debt has climbed to about $41 trilli
10-10 08:23
[The United States relaxes federal registration requirements for silencers and s
10-10 07:47
[Russia denies the emergence of new cases at the Institute of Infectious Disease
10-10 07:22
[Overnight global news you need to know on Saturday: Trump said Russia will imme
10-10 06:32
On October 10, Moody's upgraded Ghana's foreign currency senior unsecured debt r
10-10 04:38
The three major U.S. stock indexes collectively closed higher. The Dow rose 0.83
10-10 04:00
Comments